IL4 and experimental autoimmune encephalomyelitis: The inhibitory effect of PPARD agonist was also found to be associated with an increase of cytokine IL-4 and IL-10 expression and decreased IL-12 and IL-23 expression in the CNS confirming the modulatory effect of PPARD agonist in experimental autoimmune encephalomyelitis (131).